Fast-track Discharge With Telemedicine

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-30

Study Completion Date

2021-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of discharge after arrival at emergency unit, Kolding Hospital combined with treatment and rehabilitation in the home either by telemedicine or the usual treatment

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Mobile Transmission of Prehospital Vital Signs to the Emergency Department

NCT02090452

Telemedicine Triage Emergency Medical Service

COMPLETED NA

Pre-hospital Notification of Injured Patients Presenting to Trauma Centres in India

NCT02877342

Major Trauma

UNKNOWN

WARD-Home - Continuous Monitoring of Vital Parameters After Discharge

NCT05223504

Vital Sign Clinical Deterioration

COMPLETED

Telemedical Support for Prehospital Emergency Medical Service

NCT02617875

Emergency

COMPLETED NA

Continuous Monitoring of Vital Signs at Home (WARD HOME II)

NCT06077851

Vital Sign Monitoring Clinical Deterioration Hospital At Home

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants are acute in-patients at the Medical Department, Kolding Hospital. Participants shall be informed about the project, and all screened initially within 30 minutes. After 3-4 hours adjusted treatment and possible need for new investigations are conducted. Patients are randomized at discharge to home treatment with rounds via telemedicine with support of emergency team of nurses or hospitalization in emergency unit. Observations, treatment and rehabilitation follow the same standards and guidelines for all patients. The cohort of patients is recruited between Oct 1, 2015 until January 1, 2016. The study is a randomized quality evaluation study of patient satisfaction, of the emergency team at Kolding Municipality, re-admittance rate, use of other health services, and new services from the municipality.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Emergencies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Telemedicine

Discharge with telemedicine contact to emergency nurse, doctor, and municipality

Group Type ACTIVE_COMPARATOR

Telemedicine

Intervention Type DEVICE

Installation of videotelephone with broadband in patient's home

Control

Standard care with 24-48 h observation at emergency unit

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telemedicine

Installation of videotelephone with broadband in patient's home

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* municipal home care at admittance
* admitted to medical emergency care unit at Kolding Hospital

Exclusion Criteria

* ketoacidosis,
* hyperosmolar diabetic coma,
* serious hypercalcemia,
* acute renal insufficiency with serum-creatinin \> 175 mmol/l,
* serious cardiac failure
* septicemia
* acute coronary disease
* apoplexia cerebri
* neuroinfection
* progressive or active cancer
* hepatic disease
* serious psychiatric disease

Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No